Ipratropium bromide 0.06% (42mcg/spray); aqueous soln ... secretions from the serous and seromucous glands lining the nasal mucosa when applied locally. <5yrs: not recommended.
This study evaluates a new aqueous nasal formulation of ipratropium bromide (Atrovent Nasal Spray 0.03%) in subjects with perennial non-allergic rhinitis in a double-blind, placebo-controlled trial.
including fexofenadine (Allegra), ipratropium bromide (Atrovent) nasal spray, and olopatadine (Pataday) eye drops. Harris has also been receiving allergen immunotherapy for the past 3 years ...
Ipratropium bromide 0.03% (21mcg/spray); aqueous soln ... secretions from the serous and seromucous glands lining the nasal mucosa when applied locally. Epistaxis, pharyngitis, nasal dryness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback